Skip to main content
Clinical Trials/ChiCTR2100054268
ChiCTR2100054268Active, not recruitingEarly Phase 1

骶神经调控术对成人膀胱直肠功能障碍性疾病的疗效分析

自筹经费1 site in 1 country50 target enrollmentStarted: January 1, 2022Last updated:

Trial Snapshot

Phase
Early Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
症状改善情况

Study Overview

Brief Summary

评估骶神经调控术对成人膀胱直肠功能障碍的疗效和安全性。

Study Design

Study Type
干预性研究
Primary Purpose
单臂
Masking
N/a

Eligibility Criteria

Ages
18 to 90 (—)
Sex
All

Inclusion Criteria

  • 临床确诊为 BBD【符合 BBD 诊断(至少存在一种下尿路症状与至少一种肠道症状(如便秘、腹泻、大便失禁等)协同发病的症状群),客观评估(排粪造影+尿动力学检测)证实】;
  • 自愿参加本研究,患者本人或法定代理人签订知情同意书。

Exclusion Criteria

  • 存在对骶神经刺激器耗材过敏;
  • 有其他肿瘤、冠心病、肝硬化、肾功能不全等病史,患有血液病,包括各种类型的白血病及出血性疾病;
  • 存在重度焦虑,严重认知障碍。

Arms & Interventions

试验组

骶神经调控干预

Outcomes

Primary Outcomes

症状改善情况

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自筹经费

Study Sites (1)

Loading locations...

Similar Trials